000			01873 a2200529 4500
005			20250515134201.0
264		0	_c20090402
008			200904s 0 0 eng d
022			_a0028-3908
024	7		_a10.1016/j.neuropharm.2008.08.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aPerrais, David
245	0	0	_aAntagonism of recombinant and native GluK3-containing kainate receptors. _h[electronic resource]
260			_bNeuropharmacology _cJan 2009
300			_a131-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlanine _xanalogs & derivatives
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aBenzodiazepines _xpharmacology
650	0	4	_aBiophysics
650	0	4	_aCell Line, Transformed
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aHippocampus _xcytology
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aKainic Acid _xpharmacology
650	0	4	_aMembrane Potentials _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMossy Fibers, Hippocampal _xdrug effects
650	0	4	_aNeuronal Plasticity
650	0	4	_aPatch-Clamp Techniques _xmethods
650	0	4	_aProtein Subunits
650	0	4	_aPyramidal Cells _xdrug effects
650	0	4	_aReceptors, Kainic Acid _xantagonists & inhibitors
650	0	4	_aRecombinant Proteins _xgenetics
650	0	4	_aSynaptic Transmission _xdrug effects
650	0	4	_aThymine _xanalogs & derivatives
650	0	4	_aTransfection
700	1		_aPinheiro, Paulo S
700	1		_aJane, David E
700	1		_aMulle, Christophe
773	0		_tNeuropharmacology _gvol. 56 _gno. 1 _gp. 131-40
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2008.08.002 _zAvailable from publisher's website
999			_c18231702 _d18231702